Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy.
about
Agm1/Pgm3-mediated sugar nucleotide synthesis is essential for hematopoiesis and developmentProtein-Losing Enteropathy: Case Illustrations and Clinical ReviewLow molecular weight heparin relieves experimental colitis in mice by downregulating IL-1β and inhibiting syndecan-1 shedding in the intestinal mucosa.Heparan sulfate proteoglycans.Matrix expansion and syncytial aggregation of syndecan-1+ cells underpin villous atrophy in coeliac disease.High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression.Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier functionThe endothelial glycocalyx: composition, functions, and visualization.Heparin and structurally related polymers attenuate eotaxin-1 (CCL11) release from human airway smooth muscle.Regulation of the receptor for TNFalpha, TNFR1, in human conjunctival epithelial cellsGlycosylation diseases: quo vadis?Protein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatment.Oral budesonide treatment for protein-losing enteropathy in Fontan-palliated patients.The failing Fontan: etiology, diagnosis and management.Protein-losing enteropathy and the Fontan operation.Plastic bronchitis in patients with fontan physiology: review of the literature and preliminary experience with fontan conversion and cardiac transplantation.Treatment of children with protein - losing enteropathy after fontan and other complex congenital heart disease procedures in condition with limited human and technical resources.Enoxaparin improves the course of dextran sodium sulfate-induced colitis in syndecan-1-deficient mice.Vertebrate food products as a potential source of prion-like α-synuclein.End-organ consequences of the Fontan operation: liver fibrosis, protein-losing enteropathy and plastic bronchitis.Syndecan-1 Acts in Synergy with Tight Junction Through Stat3 Signaling to Maintain Intestinal Mucosal Barrier and Prevent Bacterial Translocation.Syndecan-1 and heparanase: potential markers for activity evaluation and differential diagnosis of Crohn's disease.
P2860
Q28586837-E1EBD232-2125-417E-96CD-697FD00B9BF6Q29029809-10C80392-D08C-46FB-9E97-DBC2B91F27FEQ34846405-A48EE2DB-2CEE-4BF7-97A5-2720666AA3F1Q35059448-2FCD2832-706E-45E4-B7AC-FE4973C718D2Q35242505-3D844A27-D2E0-4C1E-B252-4FBF7C291CDCQ35695593-8F3631F7-2E2E-4CF4-BFA0-643B23329DADQ36227233-02FF0EA6-BDDF-4994-BB5D-D6AC56E6DC3AQ36719459-B19E78D6-FC8D-4B7B-833E-0B318EB122DDQ36736317-2AF2E534-5082-4EEC-B15E-040DE39534E7Q36968030-61519697-0D7F-4EB1-BCBC-DD1747E04CFAQ37343144-863D0277-764F-4353-A208-A5546A531192Q37846895-D66D2517-E376-4512-A8D7-62473B0A68C3Q37887563-4E526C43-4907-4A7F-A36C-C50A67C5F25CQ37895690-C594C748-68CD-4AB2-8442-F7DA109FF34FQ38003837-F246D90C-9A2C-453E-88C0-859F528BEA24Q38117343-9046D7E4-206E-4557-8B5A-7258979C29EEQ38206510-C0E65035-2115-4BB1-8AEF-D39AC1104B9AQ42947929-92AD19B6-191C-4231-AA68-E57F7A025ADCQ46252338-75FF9747-E1E5-4249-B516-310517E74145Q51760263-E6C04577-7FC6-47B4-9312-686BC4EC75A9Q53507564-B402F96F-8923-433B-BC60-2B03CE92DC4DQ54267579-968DC366-C1D0-427C-AA6C-7258450400A0
P2860
Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Heparan sulfate plays a centra ...... of protein-losing enteropathy.
@en
type
label
Heparan sulfate plays a centra ...... of protein-losing enteropathy.
@en
prefLabel
Heparan sulfate plays a centra ...... of protein-losing enteropathy.
@en
P2860
P356
P1476
Heparan sulfate plays a centra ...... of protein-losing enteropathy.
@en
P2093
Simon Murch
P2860
P304
P356
10.1074/JBC.M510722200
P407
P577
2006-01-24T00:00:00Z